DarioHealth Corp. (DRIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 10M 20M 30M Q3 '21: 16.6M Q4 '21: 20.5M Q1 '22: 25M Q2 '22: 25.9M Q3 '22: 26.9M Q4 '22: 27.7M Q1 '23: 26.7M Q2 '23: 26.6M Q3 '23: 23.5M Q4 '23: 20.4M Q1 '24: 19M Q2 '24: 19.1M Q3 '24: 23.1M Q4 '24: 27M Q1 '25: 28M Q2 '25: 27.1M Q3 '25: 24.7M Q4 '25: 22.4M Q1 '26: 21.2M Q2 '26: 21M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 6M 12M 18M Q3 '21: 4M Q4 '21: 4M Q1 '22: 6.9M Q2 '22: 6.5M Q3 '22: 7.5M Q4 '22: 9.7M Q1 '23: 8.8M Q2 '23: 9.8M Q3 '23: 8.6M Q4 '23: 6M Q1 '24: 5.2M Q2 '24: 5.9M Q3 '24: 9.2M Q4 '24: 13.3M Q1 '25: 14.7M Q2 '25: 14.9M Q3 '25: 14.1M Q4 '25: 12.7M Q1 '26: 12M Q2 '26: 12.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -63.9M Q4 '21: -76.5M Q1 '22: -78M Q2 '22: -77.4M Q3 '22: -69.5M Q4 '22: -56.8M Q1 '23: -53.3M Q2 '23: -50M Q3 '23: -51M Q4 '23: -56.2M Q1 '24: -61.6M Q2 '24: -63.8M Q3 '24: -60.3M Q4 '24: -57.7M Q1 '25: -49.3M Q2 '25: -42.3M Q3 '25: -39.8M Q4 '25: -36.7M Q1 '26: -34.6M Q2 '26: -31.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -64.2M Q4 '21: -76.8M Q1 '22: -77.7M Q2 '22: -78M Q3 '22: -71.2M Q4 '22: -62.2M Q1 '23: -59.1M Q2 '23: -57.7M Q3 '23: -57.8M Q4 '23: -59.4M Q1 '24: -53.8M Q2 '24: -50.8M Q3 '24: -47.4M Q4 '24: -42.7M Q1 '25: -44.8M Q2 '25: -44.2M Q3 '25: -42.3M Q4 '25: -41.7M Q1 '26: -40.7M Q2 '26: -35.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q3 '21: 11.4M Q4 '21: 15.3M Q1 '22: 17.4M Q2 '22: 19.4M Q3 '22: 19.4M Q4 '22: 18M Q1 '23: 17.8M Q2 '23: 16.9M Q3 '23: 15M Q4 '23: 14.4M Q1 '24: 13.8M Q2 '24: 13.2M Q3 '24: 13.9M Q4 '24: 13.8M Q1 '25: 13.3M Q2 '25: 12.2M Q3 '25: 10.7M Q4 '25: 9.7M Q1 '26: 9.2M Q2 '26: 8.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -42M Q4 '21: -50.4M Q1 '22: -58M Q2 '22: -56.8M Q3 '22: -55M Q4 '22: -47.8M Q1 '23: -34.5M Q2 '23: -33M Q3 '23: -31M Q4 '23: -30.4M Q1 '24: -38.7M Q2 '24: -40.5M Q3 '24: -39.2M Q4 '24: -38.6M Q1 '25: -32.1M Q2 '25: -26.8M Q3 '25: -26.8M Q4 '25: -25.9M Q1 '26: -25.3M Q2 '26: -25.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -42.3M Q4 '21: -50.7M Q1 '22: -58.2M Q2 '22: -57.2M Q3 '22: -55.5M Q4 '22: -48.3M Q1 '23: -35M Q2 '23: -33.5M Q3 '23: -31.5M Q4 '23: -31M Q1 '24: -39.3M Q2 '24: -40.9M Q3 '24: -39.4M Q4 '24: -38.7M Q1 '25: -32.2M Q2 '25: -26.9M Q3 '25: -26.9M Q4 '25: -26.1M Q1 '26: -25.4M Q2 '26: -25.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '15: 37.4M Q2 '20: 4.1M Q3 '20: 7.3M Q1 '21: 14M Q2 '21: 15.7M Q3 '21: 16.5M Q1 '22: 19.6M Q2 '22: 22.4M Q3 '22: 23M Q1 '23: 27.6M Q2 '23: 28.2M Q3 '23: 28.8M Q1 '24: 34.4M Q2 '24: 39.8M Q3 '24: 2M Q1 '25: 2.4M Q2 '25: 2.5M Q3 '25: 3.1M Q1 '26: 6.6M Q2 '26: 9.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 5.00 10.00 15.00 Q3 '20: 10.56 Q4 '20: 4.00 Q1 '21: 6.49 Q2 '21: 8.16 Q3 '21: 10.05 Q4 '21: 4.18 Q1 '22: 4.00 Q2 '22: 3.75 Q3 '22: 3.21 Q4 '22: 2.64 Q1 '23: 2.35 Q2 '23: 2.19 Q3 '23: 2.04 Q4 '23: 1.93 Q1 '24: 1.68 Q2 '25: 13.21 Q3 '25: 11.26 Q4 '25: 10.44 Q1 '26: 8.82 Q2 '26: 6.13 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.